Target Price | JPY1,695.83 |
Price | JPY1,458.00 |
Potential |
16.31%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Astellas Pharma 2026 .
The average Astellas Pharma target price is JPY1,695.83.
This is
16.31%
register free of charge
JPY2,200.00
50.89%
register free of charge
JPY1,300.00
10.84%
register free of charge
|
|
A rating was issued by 13 analysts: 5 Analysts recommend Astellas Pharma to buy, 7 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Astellas Pharma stock has an average upside potential 2026 of
16.31%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,912.32 | 1,955.66 |
19.25% | 2.27% | |
EBITDA Margin | 23.78% | 22.26% |
13.54% | 6.40% | |
Net Margin | 2.65% | 7.99% |
150.26% | 201.04% |
12 Analysts have issued a sales forecast Astellas Pharma 2026 . The average Astellas Pharma sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Astellas Pharma EBITDA forecast 2026. The average Astellas Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Astellas Pharma Analysts have issued a net profit forecast 2026. The average Astellas Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 28.35 | 87.33 |
198.42% | 208.04% | |
P/E | 16.69 | |
EV/Sales | 1.66 |
6 Analysts have issued a Astellas Pharma forecast for earnings per share. The average Astellas Pharma EPS is
This results in the following potential growth metrics and future valuations:
Astellas Pharma...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.